Browsing by Author "Musolino, Antonio"
Now showing items 1-3 of 3
-
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial
Im, Seock-Ah; Cardoso, Fatima; Cortés Castan, Javier; Musolino, Antonio; Saura Manich, Cristina; Rugo, Hope; Curigliano, Giuseppe (American Medical Association, 2021-04) -
Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review
Pellegrino, B.; Musolino, Antonio; Llop Guevara, Alba; Serra Elizalde, Violeta; De Silva, P.; Hlavata, Z. (Elsevier, 2020-02-01) -
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial
Im, Seock-Ah; Cardoso, Fatima; Cortés Castan, Javier; Musolino, Antonio; Escriva de Romaní Muñoz, Santiago Ignacio; Saura Manich, Cristina; Rugo, Hope; Curigliano, Giuseppe (American Society of Clinical Oncology, 2023-01-10)